Aldosterone Receptor Antagonists for Hypertension: What Do They Offer?

ISSN： 0012-6667

Source： Drugs, Vol.63, Iss.19, 2003-01, pp. : 1963-1972

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Second Generation of COX-2 Inhibitors: What Advantages Do the Newest Offer?

By Stichtenoth D.O. Frölich J.C.

Drugs, Vol. 63, Iss. 1, 2003-01 ,pp. : 33-45

Adis International

Access to resources Recommend Favorite

Combination Pharmacotherapy for Stopping Smoking: What Advantages Does it Offer?

By Ebbert Jon O. Hays J. Taylor Hurt Richard D.

Drugs, Vol. 70, Iss. 6, 2010-04 ,pp. : 643-650

Adis International

Access to resources Recommend Favorite

Combined Opioid-NMDA Antagonist Therapies: What Advantages Do They Offer for the Control of Pain Syndromes?

By Wiesenfeld-Hallin Z.

Drugs, Vol. 55, Iss. 1, 1998-01 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

Angiotensin II Receptor Antagonists in Chronic Heart Failure: Where Do They Fit?

By Houghton A.R.

Drugs, Vol. 62, Iss. 10, 2002-10 ,pp. : 1433-1440

Adis International

Access to resources Recommend Favorite

What does istradefylline have to `off'er in PD?

Inpharma, Vol. 1, Iss. 1409, 2003-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite